相似文献/References:
[1]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(06):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[2]钱文文,辛宝,任晓梅,等.基于专利分析葛根研发热点及发展趋势[J].西部中医药,2021,34(05):92.[doi:10.12174/j.issn.2096-9600.2021.05.23]
QIAN Wenwen,XIN Bao,REN Xiaomei,et al.Research and Development Hotspots and Trends of Gegen Based on Patent Analysis[J].Western Journal of Traditional Chinese Medicine,2021,34(06):92.[doi:10.12174/j.issn.2096-9600.2021.05.23]
[3]田红艳,许蕊蕊.不同产地葛根微乳提取物对链脲佐菌素2型糖尿病小鼠的降血糖作用探讨[J].西部中医药,2023,36(05):6.[doi:10.12174/j.issn.2096-9600.2023.05.02]
TIAN Hongyan,XU Ruirui.Study on Hypoglycemic Activity of Microemulsion Extract of Gegen from Different Habitats on Streptozotocin- induced Type Two Diabetes Mellitus Mice[J].Western Journal of Traditional Chinese Medicine,2023,36(06):6.[doi:10.12174/j.issn.2096-9600.2023.05.02]